These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 12628717)

  • 21. Tirofiban administration and percutaneous coronary intervention with stenting of saphenous vein graft thrombosis.
    D'andrea C; Esposito G; Piscione F; Chiariello M
    J Cardiovasc Med (Hagerstown); 2009 Nov; 10(11):875-8. PubMed ID: 19644385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of clinical outcomes in patients presenting with an acute coronary syndrome due to stent thrombosis or saphenous vein graft occlusion and undergoing percutaneous coronary intervention.
    Ota H; Mahmoudi M; Lhermusier T; Magalhaes MA; Torguson R; Satler LF; Suddath WO; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2015 Dec; 16(8):441-6. PubMed ID: 26704310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of saphenous vein graft stent implantation: single center results from use of oversized balloon catheters.
    Scavetta K; Oh C; Caldron R; Abdel-Dayem T; Al-Zaibag M; Jutzy KR; Marsa RJ; Sjolander M; Ribeiro PA
    Angiology; 1999 Nov; 50(11):891-9. PubMed ID: 10580353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial.
    Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Van den Branden F; Van Langenhove G;
    J Am Coll Cardiol; 2007 Jul; 50(3):261-7. PubMed ID: 17631219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous saphenous vein graft intervention with sequential embolic protection devices: complementing lesion anatomy with embolic protection device.
    Grow P; Rab ST
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):636-40. PubMed ID: 18942125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial.
    Brilakis ES; Lichtenwalter C; Abdel-karim AR; de Lemos JA; Obel O; Addo T; Roesle M; Haagen D; Rangan BV; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S
    JACC Cardiovasc Interv; 2011 Feb; 4(2):176-82. PubMed ID: 21349456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case-control registry of excimer laser coronary angioplasty versus distal protection devices in patients with acute coronary syndromes due to saphenous vein graft disease.
    Niccoli G; Belloni F; Cosentino N; Fracassi F; Falcioni E; Roberto M; Panico RA; Mongiardo R; Porto I; Leone AM; Burzotta F; Trani C; Crea F
    Am J Cardiol; 2013 Nov; 112(10):1586-91. PubMed ID: 23993124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Saphenous vein graft intervention.
    Lee MS; Park SJ; Kandzari DE; Kirtane AJ; Fearon WF; Brilakis ES; Vermeersch P; Kim YH; Waksman R; Mehilli J; Mauri L; Stone GW
    JACC Cardiovasc Interv; 2011 Aug; 4(8):831-43. PubMed ID: 21851895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical experiences with the PercuSurge GuardWire--a new system for prevention of peripheral embolisms in catheter interventions on degenerated coronary artery venous bypasses].
    Müller R; Gerckens U; Staberock M; Grube E
    Z Kardiol; 2000 Apr; 89(4):316-22. PubMed ID: 10868006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of a self-expanding super-elastic all-metal endoprosthesis; to treat degenerated SVG lesions: the SESAME first in man trial.
    Abizaid A; Weiner B; Bailey SR; Londero H
    Catheter Cardiovasc Interv; 2010 Nov; 76(6):781-6. PubMed ID: 20549692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravascular ultrasound findings that are predictive of no reflow after percutaneous coronary intervention for saphenous vein graft disease.
    Hong YJ; Jeong MH; Ahn Y; Kang JC; Mintz GS; Kim SW; Lee SY; Kim SY; Pichard AD; Satler LF; Waksman R; Weissman NJ
    Am J Cardiol; 2012 Jun; 109(11):1576-81. PubMed ID: 22440118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of distal embolization during saphenous vein graft lesion angioplasty. Experience with a new temporary occlusion and aspiration system.
    Carlino M; De Gregorio J; Di Mario C; Anzuini A; Airoldi F; Albiero R; Briguori C; Dharmadhikari A; Sheiban I; Colombo A
    Circulation; 1999 Jun; 99(25):3221-3. PubMed ID: 10385493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial.
    Mauri L; Cox D; Hermiller J; Massaro J; Wahr J; Tay SW; Jonas M; Popma JJ; Pavliska J; Wahr D; Rogers C
    J Am Coll Cardiol; 2007 Oct; 50(15):1442-9. PubMed ID: 17919563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical experiences using the FilterWire EX for distal embolic protection during complex percutaneous coronary interventions.
    Lev E; Teplitsky I; Fuchs S; Shor N; Assali A; Kornowski R
    Int J Cardiovasc Intervent; 2004; 6(1):28-32. PubMed ID: 15204170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the slow-release polymer-based paclitaxel-eluting Taxus-Express stent with the bare-metal Express stent for saphenous vein graft interventions.
    Wöhrle J; Nusser T; Kestler HA; Kochs M; Hombach V
    Clin Res Cardiol; 2007 Feb; 96(2):70-6. PubMed ID: 17146605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of the Proxis embolic protection device for guide anchoring and stent delivery during complex saphenous vein graft interventions.
    Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2009; 10(3):183-7. PubMed ID: 19595401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptide-treated stent graft for the treatment of saphenous vein graft lesions: first clinical results.
    Hamm CW; Schäachinger V; Münzel T; Maikowski C; Bonzel T; Köster R; Rau M; Zeiher AM
    J Invasive Cardiol; 2003 Oct; 15(10):557-60. PubMed ID: 14519886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-hospital and long-term results of stent deployment compared with balloon angioplasty for treatment of narrowing at the saphenous vein graft distal anastomosis site.
    Gruberg L; Hong MK; Mehran R; Mintz GS; Kornowski R; Lansky AJ; Kent KM; Pichard AD; Satler LF; Dangas G; Wu H; Stone GW; Leon MB
    Am J Cardiol; 1999 Dec; 84(12):1381-4. PubMed ID: 10606108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contemporary use of embolic protection devices in saphenous vein graft interventions: insights from the stent of saphenous vein grafts trial.
    Heuser RR
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):594. PubMed ID: 21351235
    [No Abstract]   [Full Text] [Related]  

  • 40. Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial.
    Cohen DJ; Murphy SA; Baim DS; Lavelle TA; Berezin RH; Cutlip DE; Ho KK; Kuntz RE;
    J Am Coll Cardiol; 2004 Nov; 44(9):1801-8. PubMed ID: 15519010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.